2023-02-24
Notice of Completion of Series A Funding of Approximately 560 Million Yen
CTBE has completed Series A Funding in January 2023. A total of approximately 560 million yen in series A funding was raised through the following investors.
Waseda Innovation Fund No. 3 Investment Partnership
Teijin Limited
Japan Science and Technology Agency
AXA Life Insurance Co., Ltd.
NextG Investment Business Limited Liability Partnership
Sun Global Co., Ltd.
With this funding, CTBE will accelerate the commercialization of artificial ligaments for anterior cruciate ligament reconstruction surgery.
2023-04-07
CTBE Selected for AMED “Advanced Medical Devices and Systems Development Project”
2023-02-24
Notice of Completion of Series A Funding of Approximately 560 Million Yen
2023-02-16
Our CEO, Chiaki Waki presented at MedTech Woman’s Career Talk Event on February 6th, 2023
2023-01-28
Our CEO, Chiaki Waki will present at ”Yokohama Japan Health Tech and Wellness Startups Pitch Event” on January 31st 4pm to 6pm PST.
2023-01-25
Our board chairman, Yoji Jokura, will present at Life Innovation Seminar on January 31st, 2023